Combining the serum pepsinogen level and Helicobacter pylori antibody test for predicting the histology of gastric neoplasm. Issue 6 (June 2014)
- Record Type:
- Journal Article
- Title:
- Combining the serum pepsinogen level and Helicobacter pylori antibody test for predicting the histology of gastric neoplasm. Issue 6 (June 2014)
- Main Title:
- Combining the serum pepsinogen level and Helicobacter pylori antibody test for predicting the histology of gastric neoplasm
- Authors:
- Choi, Hong Seok
Lee, Sun‐Young
Kim, Jeong Hwan
Sung, In‐Kyung
Park, Hyung Seok
Shim, Chan Sup
Jin, Choon Jo - Abstract:
- <abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="cdd12144-sec-0001" sec-type="section"> <title>Objective</title> <p>To determine whether the combination test of serum pepsinogen (PG) levels and <italic>Helicobacter pylori</italic> (<italic>H. pylori</italic>) antibody was effective for predicting the incidence and histology of gastric neoplasms.</p> </sec> <sec id="cdd12144-sec-0002" sec-type="section"> <title>Methods</title> <p>This study included asymptomatic Korean adults who underwent esophagogastroduodenoscopy with blood tests for PG levels and <italic>H. pylori</italic> immunoglobulin G antibody test on the same day. Participants with extragastric malignancy, history of <italic>H. pylori</italic> eradication or gastric neoplasms, or recent antacid medication were excluded. Gastric atrophy was defined as a serum PG I/II ratio ≤3.0 and PG I ≤70 ng/mL. The participants were classified into four groups according to the presence (+) or absence (−) of gastric atrophy and <italic>H. pylori</italic> infection.</p> </sec> <sec id="cdd12144-sec-0003" sec-type="section"> <title>Results</title> <p>Of the 3328 included participants, 17 were incidentally diagnosed as having either gastric adenoma or carcinoma. The incidence of gastric neoplasm was highest in the gastric atrophy (+)/H. pylori (−) group (4.17%; OR 25.8, <italic>P</italic> = 0.009), but the neoplasm exhibited the least advanced histology. The gastric atrophy (−)/H. pylori<abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="cdd12144-sec-0001" sec-type="section"> <title>Objective</title> <p>To determine whether the combination test of serum pepsinogen (PG) levels and <italic>Helicobacter pylori</italic> (<italic>H. pylori</italic>) antibody was effective for predicting the incidence and histology of gastric neoplasms.</p> </sec> <sec id="cdd12144-sec-0002" sec-type="section"> <title>Methods</title> <p>This study included asymptomatic Korean adults who underwent esophagogastroduodenoscopy with blood tests for PG levels and <italic>H. pylori</italic> immunoglobulin G antibody test on the same day. Participants with extragastric malignancy, history of <italic>H. pylori</italic> eradication or gastric neoplasms, or recent antacid medication were excluded. Gastric atrophy was defined as a serum PG I/II ratio ≤3.0 and PG I ≤70 ng/mL. The participants were classified into four groups according to the presence (+) or absence (−) of gastric atrophy and <italic>H. pylori</italic> infection.</p> </sec> <sec id="cdd12144-sec-0003" sec-type="section"> <title>Results</title> <p>Of the 3328 included participants, 17 were incidentally diagnosed as having either gastric adenoma or carcinoma. The incidence of gastric neoplasm was highest in the gastric atrophy (+)/H. pylori (−) group (4.17%; OR 25.8, <italic>P</italic> = 0.009), but the neoplasm exhibited the least advanced histology. The gastric atrophy (−)/H. pylori (−) group exhibited the lowest incidence of gastric neoplasm (0.17%) but the most advanced histology.</p> </sec> <sec id="cdd12144-sec-0004" sec-type="section"> <title>Conclusion</title> <p>A combination of serum PG levels and <italic>H. pylori</italic> antibody test is useful for detecting gastric neoplasms based on the slow gastric carcinogenesis pathway progressing from gastric adenoma to Lauren's intestinal‐type gastric cancer, but not for those with advanced histology such as Lauren's diffuse‐type gastric cancer.</p> </sec> </abstract> … (more)
- Is Part Of:
- Journal of digestive diseases. Volume 15:Issue 6(2014:Jun.)
- Journal:
- Journal of digestive diseases
- Issue:
- Volume 15:Issue 6(2014:Jun.)
- Issue Display:
- Volume 15, Issue 6 (2014)
- Year:
- 2014
- Volume:
- 15
- Issue:
- 6
- Issue Sort Value:
- 2014-0015-0006-0000
- Page Start:
- 293
- Page End:
- 298
- Publication Date:
- 2014-06
- Subjects:
- Digestive organs -- Diseases -- Periodicals
Gastroenterology -- Periodicals
616.3 - Journal URLs:
- http://www.blackwellpublishing.com/journal.asp?ref=1751-2972&site=1 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/1751-2980.12144 ↗
- Languages:
- English
- ISSNs:
- 1751-2972
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4969.606000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 4265.xml